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Analysis of cellular energetics is central to understanding metabolic diseases including diabetes and
cancer. The two most commonly used methods to monitor cellular respiration are the Seahorse-XF
system, and Glo™ assays, which are considered “gold standards”. These commercial methods measure
energetics indirectly and require considerable ﬁnancial investment. Here we describe an alternative
assay that enables accurate quantiﬁcation of NADH turnover and that is affordable. This method mea-
sures resazurin reduction to resoruﬁn at rising concentrations in the presence of puriﬁed mitochondrial
extracts until NADH becomes a rate-limiting factor. This indicates the maximal level of NADH turnover in
each sample and therefore infers metabolic activity. Here we compare MRC5, MCF7 and MDA231 cell
lines which have differing metabolic proﬁles.
© 2019 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cellular metabolism is a balance between activities of the tri-
carboxylic acid (TCA) cycle, glutaminolysis and the electron trans-
port chain (ETC), which are based in the mitochondria, and
glycolysis and the pentose phosphate pathway (PPP), which are
based in the cytosol. The ATP yield from glycolysis is highly inef-
ﬁcient: it generates 2 molecules of ATP per molecule of glucose,
whereas up to 36 are produced by oxidative phosphorylation
(OxPhos; [1]. However, the main advantage of glycolysis is that,
unlike OxPhos, it does not produce reactive oxygen species (ROS),
which can cause signiﬁcant damage to the cell, particularly to the
DNA and mitochondria (Reviewed by Ref. [2]. Moreover, glycolysis
generates secondary metabolites that can be used as substrates to
fuel ﬂux through the PPP including the essential nucleic acid pre-
cursor ribose-5-phosphate (R5P), aromatic amino acid precursor
erythrose-5-phosphate (E5P) [4]. During tumourigenesis, cellular
metabolism is often skewed towards glycolysis, a phenomenon
known as the “Warburg Effect” [5].(S.P. Wheatley).
n open access article under the CExamining highly complex metabolic pathways in cells is chal-
lenging. The gold standard assays rely on by-products or reduction
of a substrate as means for indirect measurement of cellular
glycolytic load. For example; the Seahorse XF Glycolytic Rate Assay
by Agilent utilises the symport of lactatewith protons out of the cell
in combination with carbonic acid derived mitochondrial acidiﬁ-
cation to deduce cellular glycolytic load. The Glucose-Glo™ Assay
(Promega) is an enzymatic assay that quantiﬁes the concentration
of remaining glucose in “spent” medium. This is done by in vitro
glucose dehydrogenase activity, reducing NADþ to NADH supplying
the necessary co-factor, NADH, for pro-luciferin reductase to
generate a substrate for luciferase. Glucose concentration can then
be inferred from the relative ﬂuorescence between samples.
As the assays described above are both indirect and costly, we
have developed a direct and cost-effective alternative method to
analyse cellular respiration, which can be used for cells grown in 2D
monolayer, suspension, or in 3D. This method does not measure
cellular viability like many commercially available kits (Abcam
ab129732 for example). It is instead, a reﬁnement of one described
in part by Ref. [6]; and by Ref. [7]; where resazurin in the presence
of oxidative phosphorylation inhibitors, such as rotenone and
antimycin A, is used as an indicator of mitochondrial health. The
method described here also takes observations by Ref. [8] intoC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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fect of aﬂuorescent dihydroresoruﬁn on the result.
2. Method
2.1. Preparation of mitochondrial extracts
Human embryonic lung ﬁbroblasts (MRC5), and human breast
cancer cells (MCF7 and MDA231) were grown in standard 2D
monolayer, harvested by scraping and washed in ice-cold PBS
(centrifuged at 300 g for 5min at 4 C). PBS was discarded and
pellets resuspended in ice-cold extraction buffer (200mmol l-1
Mannitol, 70mmol l-1 Sucrose, 1mmol l-1 EGTA, 10mmol l-1 HEPES,
pH 7.5) supplemented with protease and kinase inhibitors, and
lysed with 30 strokes in a 2 cm3 glass Dounce homogeniser. Un-
lysed cells were then removed by centrifugation (500 g for
5min at 4 C), the supernatant was retained, and centrifuged at
1000 g (10min, 4 C) to precipitate nuclei, which were also dis-
carded. The supernatant was ﬁnally centrifuged at 10,000 g
(20min, 4 C) to pellet mitochondria, which were resuspended in
cold extraction buffer and spun again at 10,000 g (20min, 4 C) to
washmitochondria. At this point the supernatant was removed and
the pellet resuspended in Locke’s Buffer (154mmol l-1 NaCl,
5.6mmol l-1 KCl, 2.3mmol l-1 CaCl2, 1mmol l-1 MgCl2, 3.6mmol l-1
NaHCO3, 5mmol l-1 glucose and 5mmol l-1 HEPES pH 7.5). Protein
concentration was assessed by Bradford assay.
2.2. Mitochondrial respiration assay
20 mg of mitochondrial protein extract was diluted in 25 ml ofFig. 1. Plate layout for mitochondrial activity assay. A, layout of black walled 96-well pla
blanks and standards. B, 2x concentrated resazurin and resoruﬁn, twofold serially diluted fr
plate B, into plate A.complete medium (DMEM,10% FCS, 1mmol l-1 glutamine) to a ﬁnal
concentration 0.8 mg ml-1 and samples transferred to a glass-bottom
black-walled 96-well plate (Eppendorf, CLS3904) in duplicate, see
Fig. 1A. In a second, normal 96-well plate, serial dilutions of resa-
zurin and resoruﬁn solutions were prepared at double the ﬁnal
working concentration, as shown in Fig. 1B. Finally, the contents of
plates A (mitochondrial extracts/medium diluent) and B (resazurin/
resoruﬁn solutions) were combined in equal volumes (25 ml) into a
black 96-well plate, (see Fig. 1C), and the plate incubated at 37 C,
5% CO2 in a humidiﬁed atmosphere. After 1 h sample absorbance
was measured using a spectrophotometer (BMG Labtech, FLUOstar
Galaxy) with excitation set at 530 nm and emission at 590 nm. For
rotenone treatment, 1 mM rotenone was added to isolated mito-
chondria at timepoint 0 h and left to act during the course of the
assay.
All reagents were from Sigma unless otherwise stated.
3. Results
To determine NADH turnover, and thus the extent of OxPhos in
each cell line, a series of calculations were made. First the 590 nm
emission values from the resoruﬁn standards (Fig.1C, columns 8e9,
rows B-G), were used to plot a standard curve, whichwas expressed
in arbitrary units (AU), (Fig. 2A). Next, any background 590 nm
signal from the resazurin blanks was subtracted from the corre-
sponding 590 nmmitochondrial values. Values less the background
were then transformed through the standard curve in Fig. 2A to
calculate the resoruﬁn concentration in eachmitochondrial sample.
The resoruﬁn concentrations obtainedwere then plotted against
the original resazurin concentration to produce the Michaelis-te with mitochondrial extracts and wells containing 25 ml of medium as a diluent for
om 500 mmol l-1 to 15.625 mmol l-1. C, a twofold dilution of resazurin and resoruﬁn from
Fig. 2. Mitochondrial metabolic load MRC5 cells with and without Rotenone treatment. A, resoruﬁn standard curves, no treatment: y¼ 1132.8ln(x)-775.85; R2¼ 0.9576;
rotenone: y¼ 1025.1ln(x)-544.47; R2¼ 0.9335. B, Michaelis-Menten curves for treated and untreated mitochondrial extracts. C, Vmax calculated in B, representing maximal NADH
turnover analysed by two-tailed unpaired t-test with Welch’s correction (****, P < 0.0001). D, Vmax of rotenone treated MRC5 cells over time, as a percentage of the relevant control.
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with resazurin in excess, in this experiment NADH is the only
limiting factor, thus the resoruﬁn concentration can be used to
calculate the rate of “NADH turnover” (Vmax) of the isolated mito-
chondria directly. Fig. 2B and C clearly show that mitochondria
isolated fromMRC5 cells and treated with rotenone have a reduced
Vmax value compared to the untreated controls. This is also true of
Vmax values calculated at 30min intervals (Fig. 2D). The Vmax for
NADH for each condition obtained is expressed as nmol$s-1 as this
is more physiologically relevant to subcellular enzyme kinetics.
Note that a Michaelis-Menten curve could not ﬁt data generated at
15min or 180min, as the signal-noise was too high at 15min and
variation too large at 180min. These limitations led us to conclude
that the optimum time to take readings was between 30min and
120min.
To demonstrate the applicability of this method we compared
the metabolic load (NADH turnover) of two malignant breast can-
cer cell lines: MCF7 and MDA231. As shown in Fig. 3B and C, the
data obtained clearly indicate that MCF7 cells reduce resazurin
twice as quickly as MDA231 cells (Vmax¼ 2.5 nmol s-1 versus
1.2 nmol s-1). We then calculated the Michaelis constants (kM) for
each, ie. the concentration at which half the NADH-dependent
mitochondrial enzymes were oxidised from NADH to NADþ. As
shown in Fig. 3D, these were also signiﬁcantly different for the two
lines: 16.25 mmol l-1 for MCF7, versus 2.6 mmol l-1 for MDA231.
4. Discussion
This NADH-turnover assay is simple way to measure the meta-
bolic load of a cell population. Based on oxidation of NADH toNADþ,
it measures the reduction of resazurin to resoruﬁn as follows:
NADHþ resazurinþ Hþ /enzymeNADþ þ resorufinþ H2OIn this reaction, assuming there is a steady ﬂux of NADH and
NADþ, assaying the same mass of mitochondria in the presence of
increasing concentrations of resazurin until the resazurin is present
in excess (>32.5 mmol l-1 for MCF7, and >5.2 mmol l-1 for MDA231, as
assessed from 2xkM), mitochondrial NADH turnover can be quan-
tiﬁed directly from the conversion reaction. This is because, when
resazurin is in excess, NADH becomes the principle limiting factor
in the reaction and thus Vmax on a Michaelis-Menten curve in-
dicates at which concentration NADH limits the reaction. Higher
Vmax values infer a higher rate of oxidative phosphorylation.
In this example we compared the metabolic load of mitochon-
dria isolated from two breast cancer cell lines, grown in 2D
monolayer culture. The data report that MCF7 cells are much more
efﬁcient at OxPhos thanMDA231 cells, which is consistent with the
metabolic landscape in non-migratory and metastatic cancers
represented by MCF7 and MDA231 cells respectively [9e12].
Furthermore, the dependence of MDA231 cells on oxygen-
independent metabolism suggests that these cells derive from a
population which experienced sustained hypoxia during tumouri-
genesis [3,13e15]. A Vmax value as low as that observed for
MDA231 cells suggests minimal NADH production via oxidation of
NADH to NADþ by NADH dehydrogenase, and thus low OxPhos.
Minimal NADH production means there must also be minimal
glutaminolysis as entry into the TCA cycle by glutamate via a-
ketoglutarate would cause NADþ reduction.
In conclusionwe have described a simple, quick and economical
method to measure OxPhos in isolated mitochondria that can be
used to report mitochondrial metabolic load. There is a trade-off
between accuracy and cost, but this assay provides a good “ﬁrst
port of call” for research interested in metabolic dysregulation. If
one is only monitoring metabolism, earlier time points can be used
(15 and 30min), however, if a treatment is incorporated into the
experimental design, 1 h is more suitable as this allows time for the
treatment to take effect. Note that beyond 1 h the assay becomes
Fig. 3. Mitochondrial metabolic load of consecutive passages of MCF7 and MDA231 cells. A, resoruﬁn standard curves, MCF7: y¼ 1142.2ln(x)-1522.9; R2¼ 0.9692; MDA231:
y¼ 1061.3ln(x)-1390.4; R2¼ 0.9869. B, Michaelis-Menten curves for MCF7 and MDA231 mitochondrial extracts. C, Vmax calculated in B, representing maximal NADH turnover
analysed by two-tailed unpaired t-test with Welch’s correction (****, P < 0.0001). D, kM calculated in B, analysed by two-tailed unpaired t-test with Welch’s correction (****,
P < 0.0001).
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droresoruﬁn is a colourless and aﬂuorescent compound formed
from resoruﬁn oxidation that has recently been reported to affect
the ﬂuorometric “Amplex Red” assay [8]. Another useful parameter
in this assay, with respect to mitochondrial homeostasis is the mass
of mitochondria as a function of the number of cells or mass of
tissue from which they are prepared. Identical calculated Vmax be-
tween two samples may still inform on altered mitochondrial dy-
namics and behaviour if the mitochondrial mass of the relative
samples is different.
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